Chimeric calicivirus-like particles elicit specific immune responses in pigs.
Virus-like particles (VLPs) have received considerable attention due to their potential application in veterinary vaccines and, in particular, VLPs from rabbit haemorrhagic disease virus (RHDV) have successfully shown to be good platforms for inducing immune responses against an inserted foreign epitope in mice. The aim of this study was to assess the immunogenicity of chimeric RHDV-VLPs as vaccine vectors in pigs. For this purpose, we have generated chimeric VLPs containing a well-known T epitope of 3A protein of foot-and-mouth disease virus (FMDV). Firstly, RHDV-VLPs were able to activate immature porcine bone marrow-derived dendritic cells (poBMDCs) in vitro. Secondly, pigs were inoculated twice in a two-week interval with chimeric RHDV-VLPs at different doses intranasally or intramuscularly. One intramuscularly treated group was also inoculated with adjuvant Montanide™ ISA 206 at the same time. Specific IgG and IgA antibodies against RHDV-VLPs were induced and such levels were higher in the adjuvanted group compared with other groups. Interestingly, anti-RHDV-VLP IgA responses were higher in groups inoculated intramuscularly than those that received the VLPs intranasally. Two weeks after the last immunisation, specific IFN-γ-secreting cells against 3A epitope and against RHDV-VLPs were detected in PBMCs by ELISPOT. The adjuvanted group exhibited the highest IFN-γ-secreting cell numbers and lymphoproliferative specific T cell responses against 3A epitope and RHDV-VLP. This is the first immunological report on the potential use of chimeric RHDV-VLPs as antigen carriers in pigs.
Centre de Recerca en Sanitat Animal, UAB-IRTA, Campus de la Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
E
E
Crisci
L
L
Fraile
N
N
Moreno
E
E
Blanco
R
R
Cabezón
C
C
Costa
T
T
Mussá
M
M
Baratelli
P
P
Martinez-Orellana
L
L
Ganges
J
J
Martínez
J
J
Bárcena
M
M
Montoya
D000209:Acute-Phase Proteins / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D000918:Antibody Specificity; D016207:Cytokines / Q000378:metabolism; D003713:Dendritic Cells / Q000276:immunology / Q000378:metabolism; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry / Q000276:immunology*; D017929:Hemorrhagic Disease Virus, Rabbit / Q000276:immunology*; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D008297:Male; D008969:Molecular Sequence Data; D013552:Swine / Q000276:immunology; D058425:Vaccines, Virus-Like Particle / Q000276:immunology*; D014764:Viral Proteins / Q000737:chemistry / Q000276:immunology
D000209:Acute-Phase Proteins; D000914:Antibodies, Viral; D016207:Cytokines; D018984:Epitopes, T-Lymphocyte; D058425:Vaccines, Virus-Like Particle; D014764:Viral Proteins